Shuhei Kamiyama

Years Active: 2024-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Toko Saito, Hirokazu Nagai, Koji Izutsu, Kiyoshi Ando, Tadahiko Igarashi, Tohru Izumi, Yasuo Ohashi, Shuhei Kamiyama, Kenichi Ishizawa, Kensei Tobinai
A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma. Japanese journal of clinical oncology (2024)
Toko Saito, Hirokazu Nagai, Koji Izutsu, Kiyoshi Ando, Tadahiko Igarashi, Tohru Izumi, Yasuo Ohashi, Shuhei Kamiyama, Kenichi Ishizawa, Kensei Tobinai
A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma. Japanese journal of clinical oncology 54 (4) (2024)
Toko Saito, Hirokazu Nagai, Koji Izutsu, Kiyoshi Ando, Tadahiko Igarashi, Tohru Izumi, Yasuo Ohashi, Shuhei Kamiyama, Kenichi Ishizawa, Kensei Tobinai
A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma. Japanese journal of clinical oncology 54 (4) (2024)

Shuhei Kamiyama.css-eqlu8i{font-size:small;padding-left:4px;}